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Breast Cancer Fatalism: The Role of Women’s 
Perceptions of the Health Care System
Allyson G. Hall, PhD
Amal J. Khoury, PhD, MPH
Ellen D. S. Lopez, PhD
Nedra Lisovicz, PhD, MPH, CHES
Amanda Avis-Williams, MPH, CHES
Amal Mitra, MD, DrPH
Abstract: Cancer fatalism, which can be understood as the belief that cancer is a death sen-
tence, has been found to be a deterrent to preventive cancer screening participation. This 
study examines factors associated with breast cancer fatalism among women. We analyzed 
data from a 2003 survey of women 40 years of age. The survey collected information about 
respondents’ knowledge and attitudes regarding breast health. Analyses compared the 
characteristics of women who reported and those who did not report a fatalistic attitude. 
Women with a fatalistic attitude were more likely to be African American, to have a family 
history of breast cancer, to rate their quality of care as fair or poor, to believe that not much 
could be done to prevent breast cancer, to believe that breast cancer could not be cured if 
found early, and to believe that treatment could be worse than the disease. 
Key words: Fatalism, cancer, breast cancer, health survey.
Breast cancer is a major public health issue.1–4 It was estimated that during 2007, 178,480 new cases of female invasive breast cancer would be diagnosed, and 40,460 
deaths would be attributed to the disease.5 Overall, breast cancer mortality rates have 
declined since 1990 due to advances in early detection and treatment options, and 
possibly due to the reductions in the use of hormone-replacement therapy.2,6,7 The rate 
of women reporting ever having had a mammogram has risen substantially, from just 
under 30% in 1987 to nearly 70% in 2003.8
While these overall figures are encouraging, disparities exist between subgroups 
of women. Although White women experience a higher breast cancer incidence rate, 
African American women are more likely to die from the disease. In 2003, female age-
adjusted breast cancer incidence rates were 125.7 and 119.2 per 100,000 for White and 
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Black women, respectively. However, age-adjusted mortality rates were 25.4 and 34.4 
per 100,000 for White and Black women.8 A meta-analysis of studies that examined 
survival differences between Black and White patients for all forms of cancer found 
that, when treatment was comparable, only modest cancer-specific survival differences 
were found between African Americans and Whites. This finding led to the conclusion 
that cancer biology is not responsible for racial disparities in mortality, pointing rather 
to such possible explanations as the lack of early detection, later stage presentation, 
and differential treatment.9 
Focusing on early detection, the current literature is replete with research explor-
ing barriers to mammography screening for African American women. Both socio-
demographic and health care system–related factors have been identified. These 
factors include being older,10 having lower education and income status,11–14 being 
uninsured,11,14 lacking a usual source of care,11,13 not receiving a clinical referral,12 and 
having an inadequate understanding of cancer and screening.10,13 Findings from such 
studies have been used to develop and offer screening programs that strive to decrease 
or eliminate costs, increase access and availability of services, and promote knowledge 
and awareness. However screening rates for African Americans remain lower than those 
of other populations.12,13 Such persistent disparities suggest unique and unaddressed 
barriers to screening and treatment that may not be entirely explained by poverty, 
under-education, and limited access to care.15,16
Psychological, social, and cultural factors that affect beliefs, attitudes, and knowledge 
regarding cancer have also been found to influence women’s screening behaviors.16–18 The 
mere mention of the word cancer can evoke images of death and suffering.15 According 
to Merriam-Webster’s Dictionary, fatalism is “a philosophical doctrine holding that all 
events are predetermined in advance for all time and human beings are powerless to 
change them.”19 Fatalism has been identified as a barrier to cancer screening that merits 
further investigation.20 Over the past decade, fatalism has received increased attention 
as an independent, culturally specific variable that affects care-seeking behaviors.21,22
Definitions of fatalism are rife, and they differ across studies, contexts, and methods 
of measurement.23 Straughan and Seow conceptualized fatalism as “a belief that some 
health issues are beyond the individual’s control” and further, that fatalism involves “the 
notion of predestination, luck and faith.”24, p. 1697 Specifically with respect to cancer, fatal-
ism has been defined as “helplessness,”25, p. 22 as the belief that screening and treatment 
may be futile and surgery causes cancer to spread,26 and “the belief that death is inevitable 
when cancer is present.”27, p. 386 Research suggests that cancer fatalism is a deterrent to 
cancer screening participation, particularly among African Americans.15,16,18,20,27–30 
Fatalistic views of cancer have noteworthy consequences. In a study of colorectal 
cancer screening, elderly African Americans were not only significantly more likely to 
hold fatalistic beliefs than their White counterparts, but after demographic variables 
known to influence screening practices (age, education, income) were controlled for, 
fatalism was the only significant predictor of participation in fecal occult blood test-
ing.27 With regard to breast cancer screening, another study found that fatalism was 
prevalent among poorer and less educated populations and that, after controlling 
for education and economic status, differences in fatalism scores by race declined 
sharply.23 Fatalistic attitudes have figured importantly in explanations of why women 
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from marginalized populations may fail to seek breast cancer screening and thus often 
present with advanced-stage breast cancer.18,21 
Bearing on early detection, cancer fatalism is seen as arising and sustaining itself 
as a self-fulfilling prophecy where personal and vicarious experiences are captured 
within a cycle of late-stage cancer diagnosis, limited treatment options, and poor health 
outcomes.23,30 Freeman suggested a strong relationship between a web of poverty and 
perceptions of fatalism, in that poor people trust the health care system less than people 
who are more well off.30 Within the cultural and historic context of African American 
society, the historical forces of slavery, discrimination, segregation, and poverty are inex-
tricably woven into a social fabric where individuals and groups experience inadequate 
access to quality health care, a profound mistrust of the health care system, and a lack 
of understanding about cancer, early detection, and treatment.31 This social backdrop 
of oppression creates a fertile setting for a sense of powerlessness, hopelessness, and 
social despair that fosters fatalistic attitudes.31 Therefore, early detection is considered 
to be of no value in influencing a deadly cancer outcome. These explanations of can-
cer fatalism are focused on socioeconomic characteristics and health status, personal 
perceptions of health and health care experiences, and knowledge and understanding 
about cancer and early detection. In sum, as shown in Figure 1, a fatalistic attitude can 
arise from the interaction of several factors, including health status and family history 
of cancer, sociodemographic characteristics, and knowledge and attitudes about cancer. 
These factors can contribute to feelings of mistrust and to fatalistic attitudes. People 
who are fatalistic are less likely to engage in preventive health behavior. 
To understand cancer fatalism and its impact on breast cancer screening better, 
researchers have attempted to assess the predictors of fatalistic attitudes and beliefs. 
Parallel to sociodemographic factors associated with lower screening rates, cancer fatal-
ism has been correlated with such variables as minority status,18,20,27 older age,18,20 less 
education,18,20 and lower income.18 However, findings have been inconsistent, and stud-
ies have been limited by relatively small sample sizes, non–population-based sampling 
methods, and a focus on specific population groups. For example, fatalism research 
has often focused solely on African American populations, providing less insight into 
White populations.15,16,32 Furthermore, despite the notion that fatalism is related to lived 
experiences, there is a dearth of research on the association between cancer fatalism and 
such experiential factors as personal health care history, perceptions of the health care 
system, and knowledge and attitudes about breast cancer, screening, and treatment. 
In order to design effective health education and prevention strategies that incorpo-
rate cultural attitudes, beliefs, and experience,15 it is imperative that there be a broader 
understanding of not only how sociodemographic characteristics factors bear on fatal-
ism, but also how perceptions are linked to fatalistic beliefs. The objective of this study 
was to identify factors associated with breast cancer fatalism among women. The study 
extends current knowledge by reporting results from a large population-based survey 
that comprehensively examined women’s attitudes and beliefs about breast cancer, 
including perceptions of the health care system, and knowledge/attitudes towards breast 
cancer, screening, and treatment. 
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Methods
Survey design. We analyzed data from a statewide survey of women 40 years of age and 
older in the state of Mississippi that was conducted in the summer of 2003. American 
Cancer Society breast cancer screening guidelines recommend that women age 40 
years and older receive a mammogram every year.33 Trained interviewers at the survey 
research center of the University of Southern Mississippi conducted the survey using 
computer-assisted telephone interviewing (CATI). A sampling firm provided a repre-
sentative sample of households. The sample was screened for disconnected telephone 
lines and for households that did not include a woman 40 years of age or older. 
Knowledge 
about cancer 
and early 
detection
Figure 1. Roots of fatalism.
Health care utilization: 
early detection
Sociodemo-
graphic 
characteristics
Perceptions of their health 
and health care
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The University of Southern Mississippi’s Human Subjects Protection Review Com-
mittee approved the survey. Interviewers obtained verbal consent from participants at 
the beginning of each telephone call. Interviewers made an oral presentation, describing 
the purpose the survey and other elements of informed consent. Interviewers signed 
and dated the oral presentation each time it was read to a participant. 
Survey instrument. The survey instrument was developed using a systematic review 
of the literature and a series of focus groups. Investigators conducted six focus groups 
in 2002 with women in urban and rural parts of the state in order to collect in-depth 
qualitative data regarding breast cancer knowledge, attitudes, and behaviors. Three focus 
groups included women ages 40–49, and three groups included women ages 50 and 
older. We recruited low-income community women who did not have mammograms on 
a regular basis. Each focus group lasted two hours and was conducted by a professional 
female moderator who is a native of Mississippi and who had experience guiding group 
dynamics. A discussion guide was developed to facilitate the focus groups and included 
a series of open-ended questions with probes, where appropriate. A total of 58 women 
participated in the discussion. All participants provided written informed consent. The 
discussions were audio-taped, transcribed and analyzed for issues and themes. Findings 
were used to develop some of the survey questions and response categories. 
A systematic review of the literature was used to develop other survey questions 
and establish face validity of the questionnaire. Breast cancer experts who served on 
the advisory committee of the project established content validity of the questionnaire. 
Experts included breast health educators, managers of cancer screening and outreach 
programs, academic faculty, primary care providers, and specialty providers, including 
oncologists. 
The questionnaire was pilot-tested with 30 women 40 years of age and older. The 
women completed the telephone survey and were then asked about the meaning of 
some of the questions. Women were also asked to re-state some of the questions using 
their own words. The pilot test showed that women understood the survey and were 
able to complete it in 15–20 minutes. The wording and sequencing of some questions 
were revised based on participants’ feedback, and the survey was finalized. 
The questionnaire used closed-ended questions to collect data about primary health 
care practices, knowledge, attitudes, and practices regarding breast cancer screening 
(including mammography, clinical breast exam, and breast self exam), awareness of 
breast cancer risk factors, attitudes towards treatment, perceptions of the health care 
system, and sociodemographic characteristics.
Study variables. The outcome variable was breast cancer fatalism as measured by 
the item Breast cancer is a death sentence. Based on the literature review and on the 
formative work done by the investigators, we concluded that this survey item captures 
the theoretical concept of fatalism. Respondents strongly agreed, agreed, disagreed, or 
strongly disagreed with the statement. We compared women who reported a fatalistic 
attitude (i.e., strongly agreed or agreed with the statement) and women who did not 
report a fatalistic attitude (i.e., disagreed or strongly disagreed with the statement).
Consistent with the conceptual framework illustrated in Figure 1, we included three 
sets of explanatory variables in the analysis: sociodemographic characteristics, health 
status and family history of breast cancer, perceptions of the health care system, and 
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knowledge/attitudes towards breast cancer. Sociodemographic and health characteristics 
included age, educational attainment, race/ethnicity, household income, marital status, 
and urban/rural location. Women reported their birth years, allowing researcher to 
determine their age in years. Women reported their race/ethnicity as African American; 
White, non-Hispanic; Hispanic/Latina; American Indian; Asian American; or Other. 
The last four categories were merged into Other due to small sample sizes. Women 
also reported their education level (less than high school degree, high school degree, 
some college, college or graduate degree), annual household income (less than $10,000; 
between $10,000 and $20,000; between $20,000 and $30,000; and greater than $30,000), 
and marital status (married, living with a partner, divorced, widowed, never married). 
Data about town/city and county of residence were designated as either an urban or 
rural location.
Health status was examined using perceived health status. Perceived health status 
was rated as excellent, good, fair, or poor. Family history was defined as whether or 
not anyone in the woman’s family had been diagnosed with breast cancer. 
Six items assessed women’s perceptions of the health care system, including three 
items that measured mistrust (Rich people receive better medical care than poor 
people; Hospitals sometimes do not tell patients the truth; Health insurance affects the 
kind of care that a person receives) and three items that measured perceived racism 
(Doctors take the medical complaints of people of your race seriously; Doctors some-
times hide information from patients of your race; Hospitals provide the same care to 
people of different racial groups). Those items were derived from the work of LaVeist 
and colleagues.34,35 Women indicated whether they strongly agreed, agreed, disagreed, 
or strongly disagreed with each of the six statements. In addition, women rated their 
overall quality of care as excellent, good, fair, or poor. 
Six statements measured knowledge and attitudes regarding prevention and treat-
ment of breast cancer: 1) There is not much you can do to keep from getting breast 
cancer, 2) Breast cancer could be cured if found early, 3) Surgery exposes breast cancer 
to the air and causes it to spread, 4) Getting treated for breast cancer can be worse 
than the disease, 5) You would be able to afford treatment if diagnosed with breast 
cancer, and 6) You would rather not know if you had breast cancer. Women reported 
whether they strongly agreed, agreed, disagreed, or strongly disagreed with each of 
the six statements. 
Statistical methods. Data were entered and analyzed using SPSS version 11 for 
Windows.36 The characteristics of women who reported and who did not report a 
fatalistic attitude were compared at the bivariate level using t-tests or chi-squared tests, 
as appropriate. A binary logistic regression model examined the association between 
breast cancer fatalism and explanatory variables at the multivariate level. All independent 
variables that were associated with breast cancer fatalism at the bivariate level (p,.05) 
were entered into the regression model.
Results
Description of the sample. A total of 1,050 women responded to the survey, which 
translates into a 59.2% response rate. For purposes of this analysis, we excluded women 
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who reported a previous a breast cancer diagnosis (n563) and women who responded 
that they did not know whether or not breast cancer was a death sentence (n529). The 
analytic sample size was 958 women. Almost one in three women strongly agreed or 
agreed that breast cancer was a death sentence. Table 1 presents the characteristics of 
the final sample. Participants ranged in age between 40 and 97 years, with an average 
age of 59 years. More than half of the women had a high school degree or less educa-
tion and household incomes of less than $30,000 per year. The majority of respondents 
were White non-Hispanic (71%), married (61%), and living in rural areas (58%). 
Approximately one in three women reported that their health status was fair or poor. 
Also, one-third of the sample reported a family history of breast cancer.
Bivariate analysis. Table 1 presents the sociodemographic and health status charac-
teristics of women who agreed and disagreed that breast cancer was a death sentence. 
Women with a fatalistic attitude were more likely than women who were not fatalistic 
to be African American (41.0% vs. 24.4%, p,.001), to have low education (less than 
high school degree) (30.6% vs. 13.9%, p,.001) and low household income levels (less 
than $10,000 per year) (33.5% vs. 18.5%, p,.001). Women with fatalistic attitudes 
were, on average, two years older than other women. Urban/rural location was not 
associated with breast cancer fatalism in the bivariate analysis. In addition, women 
with fatalistic attitudes were more likely than their counterparts to report a family his-
tory of breast cancer (39.0% vs. 29.9%, p5.007) and a fair/poor health status (37.4% 
vs. 27.1%, p5.002).
Table 2 describes perceptions of the health care system and associations between 
those perceptions and breast cancer fatalism. For the quality of care rating, we report 
percent distributions for excellent/good and fair/poor ratings. For the remaining items, 
we report the proportion of women who either strongly agreed or agreed with each 
statement. Although nine of ten women rated their overall quality of care as excellent 
or good, a majority expressed some mistrust of the health care system and believed 
that health insurance affected the kind of care that a person received (79%), and that 
rich people received better care than poor people (63%). 
Women with fatalistic attitudes were more likely than their counterparts to rate 
their quality of care as fair or poor (16.7% vs. 7.3%, p,.001). In addition, women 
with fatalistic attitudes were more likely to agree that Hospitals sometimes did not tell 
patients the truth (54.7% vs. 40.6%, p,.001), that Doctors sometimes hid information 
from patients of their race (46.4% vs. 24.4%, p,.001), and that Doctors did not take 
the medical complaints of people of their race seriously (29.5% vs. 21.9%, p5.013). 
Women with fatalistic attitudes were marginally more likely to believe that Rich people 
received better medical care than poor people (67.3% vs. 61.2%, p5.077). There were 
no differences between the two groups of women regarding their perception that Health 
insurance affected the kind of care that a person received and that Hospitals provided 
the same care to people of different racial groups.
Table 3 presents results concerning women with and without breast cancer fatalism 
regarding their knowledge/attitudes of the disease. Overall, the vast majority of women 
indicated that breast cancer could be cured if found early (95%). However, sizeable 
proportions believed that surgery exposed breast cancer to the air and caused it to 
spread (46%), and that treatment could be worse than the disease (33%). One in three 
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table 1. 
SOCIODeMOgRaPHIC anD HealtH StatuS 
CHaRaCteRIStICS OF WOMen WHO agReeD OR DISagReeD 
tHat BReaSt CanCeR WaS a DeatH SentenCe
 Women by group (n, %)
 Strongly  Strongly 
 agree/ disagree/ 
 agree disagree 
 fatalistic not fatalistic total 
Characteristics n5278 n5680 n5958 p
Age (mean, SD) 59.8 (12.72) 58.1 (12.16) 59.25 (12.57) .045
Education    .000
 Less than high school 85 (30.6) 94 (13.9) 179 (18.7) 
 High school degree 96 (34.5) 224 (33.1) 320 (33.5)
 Some college  56 (20.1) 204 (30.1) 260 (27.2)
 College degree 41 (14.7) 155 (22.9) 196 (20.5)
Race/ethnicity    .000
 African American 112 (41.0) 162 (24.4) 274 (29.2)
 White, non-Hispanic 161 (59.0) 503 (75.6) 664 (70.8)
Annual household income    .000
 Less than $10,000 93 (33.5) 126 (18.5) 219 (22.9)
 $10–20,000 47 (16.9) 112 (16.5) 159 (16.6)
 $20–30,000 36 (12.9) 82 (12.1) 118 (12.3)
 More than $30,000 74 (26.6) 276 (40.6) 350 (36.5)
 Refused 28 (10.1) 84 (12.3) 112( 11.7)
Marital status    .045
 Married/with partner 156 (56.1) 427 (63.1) 583 (61.0)
 Divorced/widowed/
  never married 122 (43.9) 250 (36.9) 372 (39.0)
Location    NS
 Urban 109 (39.6) 289 (53.5) 398 (42.3)
 Rural 166 (60.4) 376 (56.5) 542 (57.7)
 Unknown  3 (1.1)  15 (2.2)  18 (1.9)
Perceived health status     .002
 Excellent/good 174 (62.6) 496 (72.9) 670 (69.9)
 Fair/poor 104 (37.4) 184 (27.1) 288 (30.1)
Family history of  .007
breast cancer 108 (39.0) 203 (29.9) 311 (32.6)
Note: p-values based on chi-square tests for cross-tabulations and t-tests for mean differences.
NS 5 not significant 
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women also reported that they would not be able to afford treatment if diagnosed. 
 Negative attitudes regarding prevention and treatment were associated with breast cancer 
fatalism. Women who agreed that breast cancer was a death sentence were more likely 
to believe that there was not much one could do to keep from getting breast cancer 
(47.1% vs. 35.7%, p5.001), and that treatment could be worse than the disease (47.5% 
table 2. 
PeRCePtIOnS OF tHe HealtH CaRe SySteM OF  
WOMen WHO agReeD OR DISagReeD tHat  
BReaSt CanCeR WaS a DeatH SentenCe
 Women by group (n, %)
 Strongly  Strongly 
 agree/ disagree/ 
 agree disagree 
 fatalistic not fatalistic total 
Characteristics n5278 n5680 n5958 p
Quality of care rating    .000
 Excellent/good 229 (82.4) 621 (91.3) 850 (88.7)
 Fair/poor 46 (16.5) 49 (7.2)  95 (9.9)
 Unknown  3 (1.1) 10 (1.5)   13 (1.4)
% strongly agree or agree with  
the following statements:
Rich people receive better 
medical care than poor people 187 (67.3) 416 (61.2) 603 (62.9) .077
Hospitals sometimes do not 
tell patients the truth 152 (54.7) 276 (40.6) 428 (44.7) .000
Health insurance affects the kind 
of care that a person receives 221 (79.5) 532 (78.2) 753 (78.6) NS
Doctors take the medical  
complaints of people of your  
race seriously 196 (70.5) 531 (78.1) 727 (75.9) .013
Doctors sometimes hide info 
from patients of your race 129 (46.4) 166 (24.4) 295 (30.8) .000
Hospitals provide the same 
care to people of different  
racial groups 160 (57.8) 400 (58.9) 560 (58.6) NS
Note: p-values are based on chi-square tests.
NS 5 not significant
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vs. 27.2%, p,.001). In addition, they were more likely to believe that they could not 
afford treatment (39.9% vs. 30.9%, p5.007) and preferred not to know if they had the 
disease (12.9% vs. 5.9%, p,.001).
Regression analysis. Table 4 presents the results of the logistic regression on breast 
cancer fatalism. Among the sociodemographic characteristics, age, race/ethnicity, and 
education were significantly associated with fatalism. Older women, African American 
women, and women with no college education were more likely than younger women, 
White non-Hispanic women, and women with a college education to agree that breast 
cancer was a death sentence. Household income and marital status were not associated 
with breast cancer fatalism at the multivariate level. Individuals with a family history 
of breast cancer were also more likely to be fatalistic. 
Among variables measuring perceptions of the health care system, two emerged as 
significant correlates of fatalism. Women who rated their quality of care as fair/poor 
and women who believed that physicians hid information from patients of their race 
were twice as likely as other women to agree that breast cancer was a death sentence. 
table 3. 
KnOWleDge/attItuDeS OF WOMen WHO agReeD OR 
DISagReeD tHat BReaSt CanCeR WaS a DeatH SentenCe
 Women by group (n, %)
 Strongly  Strongly 
 agree/ disagree/ 
 agree disagree 
% strongly agree or agree fatalistic not fatalistic total 
with the following statements n5278 n5680 n5958 p
Not much you can do to keep  
from getting breast cancer 131 (47.1) 243 (35.7) 374 (39.0) .001
Breast cancer could be cured  
if found early 254 (91.4) 655 (96.3) 909 (94.9) .002
Surgery exposes breast cancer  
to air and causes it to spread 174 (62.6) 266 (39.1) 440 (45.9) .000
Getting treated can be worse  
than the disease 132 (47.5) 185 (27.2) 317 (33.1) .000
Could afford treatment if 
diagnosed 167 (60.1) 470 (69.1) 637 (66.5) .007
Would rather not know of  
breast cancer 36 (12.9) 40 (5.9) 76 (7.9) .000
Note: p-values are based on chi-square tests.
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Finally, negative attitudes regarding prevention, detection, and treatment were strongly 
associated with fatalism. Women who believed that breast cancer could not be cured if 
found early and that treatment could be worse than the disease were more than twice 
as likely as other women to have fatalistic attitudes. Women who believed that surgery 
exposed cancer to the air and caused it to spread were 1.7 times as likely as women 
who did not hold this belief to have fatalistic attitudes.
table 4. 
lOgIStIC RegReSSIOn analySIS OF BReaSt CanCeR 
FatalISMa: eStIMateS OF ODDS RatIOS OF exPlanatORy 
VaRIaBleS anD 95% COnFIDenCe InteRValS
 Odds ratio  95% confidence 
explanatory variable of fatalism interval
Sociodemographic characteristics and health status
Age (years) 1.02* 1.00, 1.03
Education (high school or less vs. college education) 1.58* 1.10, 2.28
Race/ethnicity (African American vs. White,  
 non-Hispanic) 1.59* 1.09, 2.30
Household income (Each category vs.  
 less than $10,000) NS NS
Marital status (married vs. other) NS NS
Perceived health status (fair/poor vs. excellent/good) NS NS
Family history vs. no family history 1.43* 1.03, 2.00
Perceptions of the health care system
Quality of care (fair/poor vs. excellent/good) 1.80* 1.08, 3.00 
Hospitals tell patients the truth vs. not NS NS
Doctors take complaints of your race seriously vs. not NS NS
Doctors hide info from patients of your race vs. not 2.14*** 1.49, 3.08
Knowledge/attitudes about breast cancerb
Not much you can do to prevent breast cancer  1.38* 1.00, 1.91
Breast cancer could not be cured if found early  2.14* 1.10, 4.16
Surgery causes cancer to spread  1.68** 1.20, 2.35
Treatment can be worse the disease 2.16*** 1.56, 3.00
Would afford treatment  NS NS
Would rather not know of breast cancer  NS NS
aAgreeing or strongly agreeing that breast cancer is a death sentence
bAgreeing or strongly agreeing vs. disagreeing or strongly disagreeing
NS 5 not significant.
*p,.05
**p,.01 
***p,.001
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Discussion
In this study, fatalism was defined as whether or not a woman agreed that having breast 
cancer was a death sentence. Using this definition, all measures of sociodemographic 
and health status characteristics (except geographic location), knowledge and attitudes 
about breast cancer, and the majority of measures of perceptions of the health care 
system were found to be associated with fatalism at the bivariate level. Interestingly, 
about 80% of the sample, regardless of whether they were fatalistic or not, believed 
that health insurance affects the kind of care a person receives.
In the multivariate analysis, the variables that emerged as strong predictors of a 
fatalistic attitude were a few that measured perceptions of the health care system and 
knowledge and attitudes about breast cancer. As in other studies,18,20,27 race, age, educa-
tion, and family history of breast cancer remained statistically significant correlates of 
having a fatalistic attitude. In addition, the multivariate analysis showed that women 
who believed that doctors hid information from patients of their race, that surgery 
caused cancer to spread, and that treatment could be worse than the disease were over 
two times more likely to be fatalistic than other women. Perceptions and beliefs, likely 
based on prior experiences, are related to having a fatalistic view of cancer.
There are limitations to this study. As with all surveys, responses were self-reported 
and subject to biases associated with respondent recall and a respondents’ desire to 
report what she believed to be the correct answer. Nevertheless, even if imperfectly, 
responses reflected participants’ perceptions and therefore can help in understanding 
women’s attitudes and beliefs about breast cancer and treatment. Our sample size is 
relatively large, which makes it easier to observe statistical significance. 
The survey was conducted in Mississippi, 80% of whose counties are designated as 
rural communities and 56% of whose population lives in a rural area.37 It is unclear to 
what degree the urban/rural variable included in the analysis adequately differentiates 
between women living in rural and urban areas. Consequently, using this analysis to 
draw broad conclusions about women in states that are not similar to Mississippi in 
terms of population and geographic characteristics requires caution. 
Another limitation of this study is its inability to disentangle the web of poverty. The 
survey asked about family history of cancer. However, this was limited to one ques-
tion, and there were no items on family and personal history with illness and disease 
in general, leaving us unable to discern the linear relationship between past health 
care and other lived experiences and having a fatalistic attitude. That is, the pathways 
connecting lived experiences of low-income individuals and their friends and families, 
to beliefs about health and health care, and to fatalistic attitudes could not be fully 
explored in this analysis. Further qualitative and survey research is needed to describe 
the connections between experience with disease and a fatalistic attitude.
Finally, we measured fatalism using one item in our survey (Having cancer is a death 
sentence). The research literature uses different conceptual definitions of fatalism, and 
studies have used a variety of approaches to measure it. For example, several small 
surveys that examined the relationship between fatalism and cancer-related health 
care utilization used a scale, such as the Powe Fatalism Inventory, which represents a 
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composite of items that measure fear, pessimism, predetermination, and inevitability 
of death.20,27,28,38 Therefore, comparisons between our work and that of others must be 
done cautiously.
Conclusion
This study makes an important contribution to describing the characteristics of women 
who are likely to have fatalistic attitudes towards breast cancer. We have shown that 
sociodemographic characteristics, knowledge about cancer, and perceptions of the 
health care system are all associated with having a fatalistic attitude. Women who 
are less educated and are African American are more likely to be fatalistic than their 
counterparts. Powe suggested a relationship between mistrust of the health care system 
and fatalism.28 This study provides additional evidence for her hypothesis. Using one 
of the largest sample sizes to date, this study has demonstrated the extent to which 
perceptions and attitudes are critical determinants of whether a woman believes that 
cancer is a death sentence. While our conclusion is not definitive, our findings appear 
to indicate that beliefs about health and health care may serve as explanations for 
sociodemographic differences in fatalism, and therefore for breast health care utiliza-
tion. The key lesson is not necessarily the fact that certain perceptions and attitudes 
proved significant, but rather that knowledge, attitudes, and perceptions, in general, 
were found to be important predictors of fatalism. 
Our findings suggest strategies for addressing fatalistic beliefs towards breast cancer 
and for improving attitudes towards breast screening and treatment, particularly among 
vulnerable women. Education about breast cancer is critical and could occur in numer-
ous contexts, including one-on-one conversations with clinicians, community-based 
programs at churches and local organizations, and broad-based media campaigns. The 
purpose of such educational activities would be to dispel misperceptions of the disease 
and negative attitudes towards prevention and treatment, and to promote the view that 
survival is possible with early detection. Highlighting positive survival experiences 
would be a critical component of health promotion and education programs. 
Health care organizations also must work towards improving overall perceptions of 
the delivery systems. This can be accomplished in part by ensuring that those currently 
undergoing treatment for chronic and acute illness have positive interactions with the 
delivery system. Such interactions are necessary for building trust of the health care 
system within the community, thus encouraging greater use of appropriate health care 
services. 
Further research is warranted on the determinants of fatalism and its impact on 
health care use and health. Especially key is the need to understand better how lived 
experiences can shape attitudes and beliefs and subsequently affect utilization of 
screening and treatment programs. Such research should inform the development 
of educational and other programs designed to improve rates of screening and other 
breast health care utilization.
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